First Time Loading...

Humacyte Inc
NASDAQ:HUMA

Watchlist Manager
Humacyte Inc Logo
Humacyte Inc
NASDAQ:HUMA
Watchlist
Price: 4.41 USD 0.23% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

HUMA Price Targets Summary
Humacyte Inc

Wall Street analysts forecast HUMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUMA is 7.65 USD with a low forecast of 4.04 USD and a high forecast of 15.75 USD.

HUMA Lowest Forecast
Wall Street Target
4.04 USD
8% Downside
HUMA Average Forecast
Wall Street Target
7.65 USD
73% Upside
HUMA Highest Forecast
Wall Street Target
15.75 USD
257% Upside
Lowest
Price Target
4.04 USD
8% Downside
Average
Price Target
7.65 USD
73% Upside
Highest
Price Target
15.75 USD
257% Upside
Humacyte Inc Competitors:
Price Targets
ABOS
Acumen Pharmaceuticals Inc
274% Upside
N
NYKD
Nykode Therapeutics ASA
189% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
VIR
Vir Biotechnology Inc
217% Upside
ABOS
Acumen Pharmaceuticals Inc
274% Upside
N
NYKD
Nykode Therapeutics ASA
189% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
VIR
Vir Biotechnology Inc
217% Upside
9966
Alphamab Oncology
62% Upside
LEGN
Legend Biotech Corp
94% Upside
I
IMRX
Immuneering Corp
710% Upside
RNA
Avidity Biosciences Inc
80% Upside

Revenue
Forecast

Revenue Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
What are analyst estimates?

See Also

Summary
HUMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
HUMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HUMA stock valuation using valuation multiples.
Wall Street Estimates
HUMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HUMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HUMA's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for HUMA is 7.65 USD with a low forecast of 4.04 USD and a high forecast of 15.75 USD.

ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.